Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
BNT162b2 Approved by FDA Experimental Vaccine Feb/03/2022 60 0
Cilgavimab Emergency use authorization Experimental Antiviral Jan/26/2022 8 3
Tixagevimab Emergency use authorization Experimental Antiviral Jan/26/2022 8 3
Etesevimab Emergency use authorization Experimental Antiviral Jan/26/2022 2 11
Imdevimab Emergency use authorization Experimental Antiviral Jan/26/2022 9 8
S309 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022 9 0
mAb 222 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 7 0
mAb 253 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 6 0
mAb 58 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 6 0
mAb Beta-29 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022 2 0